Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.9 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |